Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation

Transplant Immunology

Volumn 13, Issue 4, 2004, Pages 305-311

  Zekri, Abdel Rahman N ^a   Mohamed, Waleed S ^a   Samra, Mohamed A ^b   Sherif, Ghada M ^b   El Shehaby, Amal M R ^c   El Sayed, Manal H ^d  

^a National Cancer Institute   (Egypt)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CAIRO UNIVERSITY   (Egypt)

^d AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

BTM; CMV; HBV; HCV

Indexed keywords

BUSULFAN; CYCLOSPORIN A; CYTARABINE; METHOTREXATE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEATH; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; HEALTH CARE POLICY; HEPATITIS B; HUMAN; INFECTION RISK; MALE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SAFETY; SEROCONVERSION; VIRUS INFECTION; VIRUS REACTIVATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT VS HOST DISEASE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; MALE; TISSUE DONORS;

EID: 10044236758     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2004.10.001     Document Type: Article

References (21)

1. M.M. Harowitz Uses and growth of hematopoietic cell transplantation E.D. Thomas K.G. Blume S.J. Farman Hematopoietic cell trasplantation 1999 Blackwell Cambridge (MA) 12
2. S.I. Strasser, and G.B. McDonald Hepatitis viruses and hematopoietic cell transplantation: a guide to patient and donor management Blood 93 4 1999 1127 1136
3. A. Webster, M.K. Brenner, H.G. Prentice, and P.D. Griffiths Fatal hepatitis B reactivation after autologous bone marrow transplantation Bone Marrow Transplant. 4 2 1989 207 208
4. P.M. Chen, S. Fan, J.H. Liu, T.J. Chiou, S.R. Hsieh, and R.S. Liu Reactivation of hepatitis B virus in two chronic GVHD patients after transplant Int. J. Hematol. 58 3 1993 183 188
5. B.A. Martin, J.M. Rowe, P.A. Kouides, and J.F. DiPersio Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature Bone Marrow Transplant. 15 1 1995 145 148
6. G.K. Lau, R. Liang, E.K. Chiu, C.K. Lee, and S.K. Lam Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study Bone Marrow Transplant. 19 8 1997 795 799
7. B. George, V. Mathews, A. Srivastava, and M. Chandy Infections among allogeneic bone marrow transplant recipients in India Bone Marrow Transplant. 33 3 2004 311 315
8. R. Peffault de Latour, V. Levy, T. Asselah, P. Marcellin, C. Scieux, and L. Ades Long-term outcome of hepatitis C infection after bone marrow transplantation Blood 103 5 2004 Mar 1 1618 1624 Epub 2003 Oct 23
9. D. Pillay, A. Webster, H.G. Prentice, and P.D. Griffiths Risk factors for viral reactivation following bone marrow transplantation Ann. Hematol. 64 Suppl 1992 Jun A148 A151
10. T.S. Lin, D. Zahrieh, E. Weller, E.P. Alyea, J.H. Antin, and R.J. Soiffer Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation Transplantation 74 1 2002 49 54
11. S. Saavedra, I. Jarque, G.F. Sanz, F. Moscardo, C. Jimenez, and G. Martin Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution Clin. Microbiol. Infect. 8 11 2002 725 733
12. J.R. Wingard, S. Piantadosi, W.H. Burns, M.L. Zahurak, G.W. Santos, and R. Saral Cytomegalovirus infections in bone marrow transplant recipients given intensive cytoreductive therapy Rev. Infect. Dis. 12 Suppl 7 1990 S793 S804
13. R. Boom, C.J. Sol, M.M. Salimans, C.L. Jansen, P.M. Wertheim-van Dillen, and J. van der Noordaa Rapid and simple method for purification of nucleic acids J. Clin. Microbiol. 28 3 1990 495 503
14. H. Einsele, M. Steidle, A. Vallbracht, J.G. Saal, G. Ehninger, and C.A. Muller Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique Blood 77 5 1991 1104 1110
15. A.R. Zekri, A.A. Bahnassy, S.M. Shaarawy, O.A. Mansour, M.A. Maduar, and H.M. Khaled Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and development of hepatocellular carcinoma J. Med. Microbiol. 49 1 2000 89 95
16. R. Boom, C.J. Sol, R. Heijtink, P.M. Wertheim-van Dillen, and J. van der Noordaa Rapid purification of hepatitis B virus DNA from serum J. Clin. Microbiol. 29 9 1991 1804 1811
17. A.E. Broers, R. van Der Holt, J.W. van Esser, J.W. Gratama, S. Henzen-Logmans, and V. Kuenen-Boumeester Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation Blood 95 7 2000 2240 2245
18. K. Takenaka, H. Gondo, K. Tanimoto, K. Nagafuji, T. Fujisaki, and S. Mizuno Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors The Fukuoka Bone Marrow Transplantation Group Bone Marrow Transplant. 19 3 1997 241 248
19. J.D. Meyers, N. Flournoy, and E.D. Thomas Risk factors for cytomegalovirus infection after human bone marrow transplantation J. Infect. Dis. 153 3 1986 478 488
20. H. Hebart, C. Muller, J. Loffler, G. Jahn, and H. Einsele Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation Bone Marrow Transplant. 17 5 1996 861 868
21. A. Locasciulli, M. Testa, M.G. Valsecchi, A. Bacigalupo, S. Solinas, and J.F. Tomas The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group Transplantation 68 10 1999 1486 1491